Genocea Biosciences Inc (NASDAQ:GNCA) price target set to $5.00 by HC Wainwright

ME Staff
-
0

Analyst Ratings For Genocea Biosciences Inc (NASDAQ:GNCA)

Today, HC Wainwright set its price target on Genocea Biosciences Inc (NASDAQ:GNCA) to $5.00 per share.

There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Genocea Biosciences Inc (NASDAQ:GNCA) is Buy with a consensus target price of $4.00 per share, a potential 541.75% upside.

Some recent analyst ratings include

  • 2/12/2018-Genocea Biosciences Inc (NASDAQ:GNCA) has coverage initiated with a Outperform rating and $3.00 price target
  • 2/6/2018-Genocea Biosciences Inc (NASDAQ:GNCA) gets upgraded to Buy by Needham & Company LLC with a price target of $3.00
  • 11/2/2017-Genocea Biosciences Inc (NASDAQ:GNCA) had its Overweight rating reiterated by Piper Jaffray Companies with a $5.00 price target
  • 9/26/2017-Genocea Biosciences Inc (NASDAQ:GNCA) had its Buy rating reiterated by Cowen with a $10.00 price target
  • 9/25/2017-Genocea Biosciences Inc (NASDAQ:GNCA) gets downgraded to Hold by Stifel Nicolaus with a price target of $2.50


  • On 9/13/2018 Michael Alfieri, Insider, bought 10,000 with an average share price of $0.54 per share and the total transaction amounting to $5,400.00.
  • On 9/6/2018 George Siber, Director, bought 25,000 with an average share price of $0.61 per share and the total transaction amounting to $15,250.00.
  • On 9/4/2018 George Siber, Director, bought 25,000 with an average share price of $0.62 per share and the total transaction amounting to $15,500.00.
  • On 8/31/2018 George Siber, Director, bought 25,000 with an average share price of $0.61 per share and the total transaction amounting to $15,250.00.
  • On 8/29/2018 George Siber, Director, bought 25,000 with an average share price of $0.61 per share and the total transaction amounting to $15,250.00.
  • On 1/17/2018 William D Clark, CEO, bought 25,000 with an average share price of $0.80 per share and the total transaction amounting to $20,000.00.
  • On 7/24/2017 Jonathan Poole, CFO, sold 45,000 with an average share price of $6.00 per share and the total transaction amounting to $270,000.00.

Recent Trading Activity for Genocea Biosciences Inc (NASDAQ:GNCA)
Shares of Genocea Biosciences Inc closed the previous trading session at 0.61 −0.0100 1.61% with 0.6 shares trading hands.